Stem Cell Therapy in Thailand for Knee Osteoarthritis: Costs, Evidence & What to Know

🔎 Stem Cell Therapy for Knee Osteoarthritis at a Glance

If you are researching stem cell therapy for knee osteoarthritis, you are probably trying to answer a few very practical questions:

• Could stem cell therapy actually help my knee?
• Is the evidence strong enough?
• What would I be paying for in Thailand?

‍

Here is the short version before we go deeper.

‍

‍

💰 How Much Does Stem Cell Therapy for Knee Osteoarthritis Cost in Thailand?

Publicly advertised prices suggest that some single-knee procedures start around ฿80,000 THB(about $2,500 USD), while bilateral or more extensive regenerative medicine programs can reach ฿500,000 THB (about $15,155 USD).⁸⁹

That is a wide range, and there is a reason for it.

There is no standardized national price because there is no single standardized “stem cell treatment.”

Note: These are publicly advertised examples, not an official national average.

If one clinic quotes you ฿100,000 THB (around $3,000 USD) and another ฿350,000 ($10,600 USD) don’t assume the cheaper option is lower quality or the more expensive one is better.

What matters is what each treatment actually includes, the cell product being used, and whether the protocol makes sense for your knee.

‍

🧾 What affects the price of knee stem cell therapy?

Two clinics can both call their offer “stem cell treatment for knee osteoarthritis” while including very different medical services.

Price can depend on:

• one knee or both knees;
• autologous or donor-derived cells;
• adipose, bone marrow, or umbilical-cord source;
• culture-expanded or minimally processed products;
• viable cell dose;
• number of injections;
• manufacturing and laboratory testing;
• ultrasound or other image guidance;
• X-rays or MRI;
• orthopedic assessment;
• adipose or bone-marrow harvesting;
• PRP or hyaluronic acid;
• rehabilitation and physiotherapy;
• follow-up consultations;
• additional IV MSC or supportive treatments.
  ‍

This is why comparing clinics only by the headline price can be misleading.

A lower quote may be for a simpler procedure.

A higher quote may include extensive diagnostics, rehabilitation, bilateral treatment, or additional therapies that may or may not be relevant to your knee.

‍

🧬 Does Stem Cell Therapy Actually Work for Knee Osteoarthritis?

Stem cell therapy may reduce pain and improve function in some people with knee osteoarthritis, but the evidence is not strong enough to promise a predictable result for every patient.

One of the most useful recent evidence sources is the 2025 Cochrane living systematic review of 25 randomized trials involving 1,341 people with knee osteoarthritis.²

When the researchers focused on placebo-controlled trials, stem cell injections produced modest improvements in both pain and function.

At around six months:

• pain was approximately 1.2 points better on a 0–10 scale than placebo;
• function improved by approximately 14.2 points on a 0–100 scale in the analysis used by the review.²
  ‍

Those results are encouraging, but Cochrane rated the certainty of the evidence as low.

That is an important distinction.

Low-certainty evidence does not mean “the treatment does not work.”

It means researchers are not yet confident enough to say exactly how much benefit to expect, which patients are most likely to benefit, or which treatment protocol performs best.

‍

📊 Why is the evidence still uncertain?

The biggest issue is that researchers are often studying treatments that share the same label but are not actually the same therapy.

Trials differ in:

• cell source;
• dose;
• processing;
• expansion method;
• injection protocol;
• disease severity;
• comparison treatment;
• follow-up period.
  ‍

Imagine trying to judge whether “exercise works” while combining weightlifting, swimming, sprinting, and yoga into one category.

That is similar to one of the challenges researchers face with “stem cell therapy.”

A positive study using one cell product cannot automatically validate every treatment sold under the same name.

Evidence summary: The research is promising enough to take seriously, but not standardized enough to promise the same result from every clinic, protocol, or patient.²

‍

📚 What Does the Latest 2026 Research Show?

The newest evidence is becoming more encouraging, but it still does not give us a simple yes-or-no answer.

A 2026 meta-analysis combined 24 randomized controlled trials involving 1,389 patients and found statistically significant improvements in pain, WOMAC scores, KOOS outcomes, and cartilage-volume measurements.³

At first glance, that sounds very strong.

The catch is that results varied considerably between studies.

Reported heterogeneity reached:

• 91.3% for pain;
• 75.3% for WOMAC;
• 82.5% for cartilage volume.³
  ‍

In plain English, different trials were getting very different results.

That can happen because they are using different cells, different doses, different protocols, and different patient populations.

So the takeaway is not:

“The latest research proves stem cells work.”

A more accurate conclusion is:

Recent randomized research increasingly supports potential improvements in pain and function, but researchers have not yet identified one standardized stem cell protocol that reliably produces the same results across patients.

That is where the field currently sits: more promising than it was a few years ago, but still far from standardized.

‍

🦴 Can Stem Cells Regrow Knee Cartilage?

Stem cell therapy may influence cartilage-related changes in some patients, but research has not consistently shown that it can rebuild normal, durable knee cartilage.³⁴

This matters because “cartilage regeneration” is often the claim that gets people's attention.

If you have been told your cartilage is thinning or disappearing, the idea of growing it back is naturally appealing.

But pain relief and cartilage regeneration are not the same thing.

‍

📈 Symptom improvement is not the same as cartilage regeneration

You could potentially:

• feel less pain;
• walk farther;
• climb stairs more comfortably;
• return to activities you had stopped;
  ‍

..without your cartilage returning to normal.

That is still clinically meaningful.

It is simply a different outcome from structural regeneration.

Researchers looking for true structural change may measure:

• cartilage thickness;
• cartilage volume;
• lesion size;
• synovial changes;
• joint-space progression.
  ‍

Some trials have reported encouraging MRI findings.

But current evidence does not consistently show that MSC injections restore normal cartilage or reverse established osteoarthritis.³⁴

‍

🔬 How might MSCs help if they are not simply becoming new cartilage?

The science is more interesting than the common “stem cells become cartilage” explanation.

Researchers increasingly view MSCs as biological signaling cells.

They may help influence the environment inside the joint by:

• modulating inflammatory pathways;
• releasing paracrine factors;
• influencing the joint microenvironment;
• affecting cartilage metabolism;
• supporting repair-related processes.³
  ‍

In other words, the cells may be helping to change how the joint behaves rather than simply turning themselves into a brand-new layer of cartilage.

What this means for patients: Feeling better after treatment can be meaningful.

It just should not automatically be described as proof that your lost cartilage has grown back.

‍

🇹🇭 What Does Thailand's Own Research Say About Knee Stem Cell Therapy?

Thailand is not only a place where regenerative medicine is marketed to international patients.

Thai academic and hospital institutions are also conducting clinical research.

A 2025 multicenter randomized study involving researchers associated with Suranaree University of Technology Hospital and Phramongkutklao Hospital evaluated autologous adipose-derived MSCs in 48 people with early-stage knee osteoarthritis.⁶

Participants received either:

• autologous adipose-derived MSCs; or
• hyaluronic acid.
  ‍

At six months, researchers reported favorable findings in the ADSC group involving:

• cartilage-lesion measurements on MRI;
• synovial thickness;
• WOMAC symptoms;
• functional outcomes.⁶
  ‍

For anyone researching stem cell therapy in Thailand, this is genuinely interesting.

It means the country is contributing to the scientific conversation, not simply selling treatments developed elsewhere.

‍

🧠 What does the Thailand study actually tell us?

The study adds promising local evidence, particularly for early-stage knee osteoarthritis.

But it should not be stretched beyond what it studied.

The trial involved:

• 48 participants;
• early-stage OA;
• relatively short follow-up;
• autologous adipose-derived MSCs specifically.⁶
  ‍

That matters.

A stem cell clinic in Bangkok, Phuket, Koh Samui, or Chiang Mai may offer a completely different product, such as donor-derived UC-MSCs or BMAC.

This study does not automatically prove that treatment will produce the same outcome.

Evidence for one type of cell therapy is not evidence for every treatment sold under the “stem cell” label.

That distinction can save patients from making very expensive assumptions.

‍

🧪 What Types of Stem Cell Therapy Are Used for Knee Osteoarthritis?

Stem cell therapy for knee osteoarthritis can refer to several very different biological products.

This is one of the most important things to understand before comparing clinics.

A 2026 systematic review emphasized that ADSCs, SVF, and MFAT are biologically and regulatorily different interventions and should not be treated as interchangeable simply because they all come from adipose tissue.⁴

This is where clinic comparisons can become confusing.

One clinic might say: “We use 50 million stem cells.”

Another might say: “We use your own bone marrow.”

Both sound like “stem cell therapy,” but they may represent completely different products.

‍

❓ What should you ask instead of “Do you offer stem cells?”

Ask: “What exact biological product will be injected into my knee?”

A serious answer should make clear:

• where the cells or tissue come from;
• whether they are yours or donor-derived;
• whether they are culture-expanded;
• the viable cell dose;
• how they were processed;
• which laboratory produced them;
• what release testing was performed;
• what evidence supports that specific product.
  ‍

If these basic questions produce vague answers, that matters more than an impressive-looking treatment brochure.

‍

🎯 Who May Be a Better Candidate for Knee Stem Cell Therapy?

Stem cell therapy may make more biological sense for some knees than others.

Recent research involving adipose-derived therapies suggests that people with earlier-stage Kellgren-Lawrence grade I–II osteoarthritis may show more consistent benefits than patients with more advanced disease.⁴

That does not create a simple rule. Someone with mild OA is not guaranteed to respond. Someone with severe OA is not guaranteed to fail.

But it tells us something important: the condition of the joint matters.

‍

✅ A potentially more favorable situation may include

• mild to moderate osteoarthritis;
• ongoing symptoms despite appropriate conservative treatment;
• relatively preserved joint structure;
• limited mechanical abnormalities;
• realistic goals around pain, movement, and function.

‍

⚠️ More complex cases may involve

• severe joint-space collapse;
• substantial malalignment;
• instability;
• advanced bone remodeling;
• significant meniscal or ligament damage;
• end-stage bone-on-bone arthritis.

‍

This distinction matters because a biological treatment cannot be expected to fix every mechanical problem.

If your knee is severely misaligned or structurally collapsing, the issue is no longer just inflammation or cartilage biology.

The more structurally damaged the knee becomes, the more important it is to distinguish a biological problem from a mechanical one.

This is why a proper assessment should consider imaging, alignment, stability, previous injuries, symptoms, and treatment goals before anyone decides that “stem cells” are the answer.

‍

🩻 Do Stem Cells Work for Bone-on-Bone Knee Osteoarthritis?

Stem cell therapy may still affect symptoms in some people with bone-on-bone knee osteoarthritis, but the evidence is generally less convincing in advanced disease than in earlier-stage OA.⁴

If you have been told your knee is “bone on bone,” this is probably the question you care about most.

The key is to separate two very different goals:

"Can I feel better with this treatment?"

and

"Can the treatment reverse the structural damage?"

Those are not the same question.

Someone with advanced OA may potentially experience less pain without reversing:

• major joint-space loss;
• malalignment;
• bone remodeling;
• mechanical instability.
  ‍

Trials involving KL grade IV osteoarthritis have often shown less clear advantages over conventional intra-articular treatments.⁴

There is also no robust evidence showing that stem cell injections reliably prevent knee replacement in people who would otherwise need arthroplasty.

If a clinic tells you stem cells can eliminate the need for knee replacement, ask:

‍‍"What evidence shows this in patients with my level of arthritis using the exact treatment you are proposing?"

A credible provider should be comfortable with that question.

‍

🧠 How Much Improvement Could Come From Placebo or Contextual Effects?

This is not the most glamorous part of regenerative medicine research, but it is one of the most important.

A 2025 systematic review of eight placebo-controlled randomized trials involving 467 patients found that contextual effects appeared to account for a substantial proportion of the improvement seen after MSC procedures.⁷

At six months, the analysis estimated contextual effects contributed approximately:

• 63% of observed pain improvement;
• 61% of functional improvement.⁷
  ‍

The certainty of that evidence was low, so these numbers should not be treated as exact percentages for every patient.

But the larger point matters.

When someone undergoes an expensive, sophisticated procedure they believe could change their knee, several things may influence the outcome:

• the biological treatment;
• patient expectations;
• normal fluctuations in OA symptoms;
• rehabilitation;
• physician interaction;
• other treatments;
• the overall treatment experience.
  ‍

This does not mean MSC therapy is “just placebo.”

It means a testimonial cannot tell you exactly which part of the treatment caused the improvement.

A patient saying “my knee improved 70% after stem cells” tells us something important about their experience.

It does not prove that the cells themselves caused 70% of the improvement.

That is why randomized placebo-controlled research matters so much.

‍

🛡️ What Are the Risks of Stem Cell Therapy for Knee Osteoarthritis?

Short-term safety findings from randomized studies have generally been reassuring, but long-term evidence remains more limited.³

Recent pooled analyses have not identified a clear significant increase in overall adverse events compared with control groups.³

That is encouraging.

It is not the same as saying the treatment has been proven safe over decades.

Not finding a higher rate of adverse events is not the same as proving long-term safety.

Most trials follow patients for months or a few years rather than for very long periods.³

Potential risks can vary depending on the treatment and may include:

• temporary pain;
• swelling;
• infection;
• harvest-site complications;
• immune reactions;
• risks associated with cell processing;
• uncertainty around poorly characterized biological products.
  ‍

The risk profile may also differ between autologous adipose-derived cells, donor-derived UC-MSCs, BMAC, and other preparations.

Manufacturing matters too.

A well-characterized product produced under appropriate laboratory controls is not equivalent to a product with unclear sourcing or testing.

The better question is therefore not:

“Are stem cells safe?”

It is:

“How was this specific product produced, tested, and selected for someone with my knee condition?”

‍

⚖️ How Is Stem Cell Therapy Regulated in Thailand?

Thailand is developing a more formal regulatory framework for advanced biological therapies, including cell-based treatments.

In 2026, the Thai Food and Drug Administration described its framework for Advanced Therapy Medicinal Products (ATMPs), including cell therapies, gene therapies, and tissue-engineered products.¹⁰

The framework covers areas including:

• oversight before human use;
• manufacturing requirements;
• laboratory and institutional controls;
• GMP-related requirements;
• medicine registration for products intended for commercial sale.¹⁰
  ‍

For patients, one distinction is especially important.

“Available in Thailand” does not automatically mean “Thai FDA-registered.”

At the same time, regulation is more nuanced than assuming every therapy without conventional commercial registration is automatically illegal.

Research and institutional pathways may operate differently.

That is why the best question is specific:

“Under what Thai FDA or clinical-use pathway is this exact cell product being administered?”

That question will tell you far more than asking whether “stem cells are legal in Thailand.”

‍

✅ How Should You Compare Stem Cell Clinics in Thailand?

If you are comparing stem cell clinics in Thailand, do not start with the biggest cell count or the cheapest package.

Start with the medical proposal.

A serious clinic should be able to explain what it is treating, what it is injecting, why that approach makes sense, and how the product was produced.

‍

🧬 1. What exactly is being injected?

Ask for:

• product name;
• tissue source;
• autologous or allogeneic origin;
• processing method;
• viable cell dose;
• final injection volume;
• passage number where relevant.
  ‍

You should be able to understand what is entering your knee.

‍

🏭 2. Who manufactures the cells?

Ask for the laboratory or manufacturer name and where the product is produced.

“We use certified stem cells” is not the same thing as knowing who manufactured them and under what standards.

‍

🧫 3. What testing is performed before release?

Depending on the product, documentation may include:

• sterility;
• viability;
• cellular identity or phenotype;
• endotoxin testing;
• mycoplasma testing.
  ‍

You do not need to become a cell biologist.

You do need enough information to understand whether the clinic knows exactly what it is administering.

‍

⚖️ 4. What regulatory pathway applies?

Ask:

“Under what Thai FDA or clinical-use pathway is this particular product being administered?”

A clear answer is better than a generic statement about stem cells being legal in Thailand.

‍

👨‍⚕️ 5. Who actually evaluates and treats the knee?

A sophisticated cell product does not compensate for poor orthopedic assessment.

Ask:

• who reviews your imaging;
• who decides whether you are a candidate;
• who performs the injection;
• what experience they have treating knee OA.

‍

🩻 6. How was your osteoarthritis severity determined?

A treatment recommendation should connect to your actual knee.

That may involve:

• X-rays;
• MRI where appropriate;
• Kellgren-Lawrence grade;
• alignment;
• meniscus;
• ligaments;
• stability;
• previous injuries.
  ‍

A good treatment plan should explain why this intervention fits your knee, not simply why the clinic likes using stem cells.

‍

📣 7. What outcome is being promised?

Pay close attention to claims such as:

• guaranteed cartilage regeneration;
• 90%+ success rates;
• permanent results;
• guaranteed avoidance of knee replacement.
  ‍

Ask what the percentage refers to.

• Pain relief?
• MRI findings?
• Patient satisfaction?
• Avoiding surgery?
• Was the study using the same cell product being offered to you?

‍

🔄 8. What happens if the treatment does not work?

Ask about:

• follow-up;
• rehabilitation;
• outcome assessment;
• complication management;
• alternative options.
  ‍

A good medical plan should explain what happens after the injection, not just what happens before payment.

STEMCIERGE tip: A strong proposal should become clearer as you ask questions. If basic questions about the cells, physician, laboratory, or evidence make the treatment harder to understand, keep investigating.

‍

💉 Stem Cells vs PRP vs Hyaluronic Acid for Knee Osteoarthritis

Stem cells are not the only option for knee osteoarthritis, and they should not be evaluated in isolation.

Depending on your knee, you may also be considering PRP, hyaluronic acid, corticosteroids, rehabilitation, medication, or surgery.

It is tempting to ask: “Are stem cells better than PRP?”

But that question skips the most important variable: your knee.

A better question is:

“Which option makes the most sense for the severity and mechanics of my knee, the treatments I have already tried, and what I want to achieve?”

There may not be one universally “best” injection.

There may be a best next step for your particular situation.

‍

🏃 Stem Cell Therapy Should Not Be Compared With Doing Nothing

One of the easiest ways to oversell regenerative medicine is to frame the choice as:

Stem cells or keep suffering.

Real knee osteoarthritis treatment is more complicated than that.

Depending on the patient, evidence-based management can include:

• structured exercise;
• physical therapy;
• weight management when appropriate;
• medication;
• PRP;
• other injections;
• bracing;
• biomechanical management;
• surgery when indicated.¹¹
  ‍

Stem cell therapy should therefore be evaluated as one possible part of a broader knee-management strategy.

That distinction is especially important if your main goal is avoiding surgery.

Avoiding an operation at all costs is not always the same thing as choosing the best treatment.

The goal should be to find the intervention that best fits the actual problem.

Start with the knee. Then choose the treatment. Not the other way around.

‍

✈️ Is Traveling to Thailand for Knee Stem Cell Therapy Worth It?

Thailand may be worth considering for knee stem cell therapy if you have been properly evaluated and find a treatment protocol that genuinely fits your condition.

There are several reasons international patients look at Thailand:

• established medical-tourism infrastructure;
• active regenerative medicine research;
• developed international patient services;
• access to high-quality rehabilitation;
• treatment prices that may differ from private treatment in Western countries.
  ‍

But a passport stamp does not make a treatment better.

Thailand has sophisticated providers.

It also has providers whose marketing may be more impressive than the underlying medical proposal.

A strong clinic may provide:

• transparent laboratory information;
• detailed orthopedic assessment;
• realistic expectations;
• image-guided treatment;
• structured rehabilitation;
• clear follow-up.
  ‍

Another provider may focus heavily on large cell counts, “anti-aging” bundles, and promises that are difficult to connect to published evidence.

Choose Thailand after deciding whether the proposed treatment makes sense for your knee, not before.

Thailand can influence cost, convenience, travel experience, and access.

Treatment quality still depends on the diagnosis, biological product, laboratory, physician, protocol, and patient selection.

‍

🧭 What Should You Know Before Making a Decision?

Before paying for stem cell therapy for knee osteoarthritis in Thailand, make sure you can answer 7 questions.

If you cannot, you probably do not understand the proposal well enough yet.

‍

🩻 1. What is actually wrong with your knee?

Know the severity of the osteoarthritis and whether other structural problems are involved.

“Knee pain” is not a diagnosis.

‍

🎯 2. What are you trying to achieve?

Pain reduction, walking farther, returning to golf or sport, delaying surgery, and rebuilding cartilage are very different goals.

A treatment should be judged against the outcome you actually care about.

‍

🧬 3. What biological product is being proposed?

“Stem cells” is not enough information.

Know what product is going into your knee.

‍

📚 4. What evidence supports that specific treatment?

A positive trial using adipose-derived MSCs does not automatically validate UC-MSCs, BMAC, or another preparation.

Ask for evidence relevant to the actual product being offered.

‍

🏭 5. How are the cells manufactured and tested?

This is where laboratory quality becomes part of treatment quality.

‍

💰 6. What does the entire protocol cost?

Compare everything included: diagnostics, cell product, injection, rehabilitation, follow-up, and any additional treatments.

A cheaper quote may simply contain less.

A more expensive quote may contain more without necessarily containing more value.

‍

📈 7. Are the expected outcomes realistic?

Improvement in pain and function is a more defensible expectation than guaranteed cartilage regrowth or reversal of advanced arthritis.

A good decision is not based on finding the clinic with the biggest promise.

It is based on understanding which claims are supported, which are uncertain, and which questions still need answers.

‍

📌 Key Takeaways

Stem-cell-based therapies may reduce pain and improve function for some people with knee osteoarthritis.²³

But the phrase “stem cell therapy” hides a lot of complexity.

The most important things to remember are:

• Stem cell therapy is not one standardized treatment.
• Evidence is stronger for symptom improvement than for proven cartilage regeneration.
• Earlier-stage osteoarthritis may be a more favorable treatment setting than advanced bone-on-bone disease.⁴
• Thailand has genuine local regenerative medicine research, not only medical-tourism marketing.⁶
• Knee stem cell therapy prices in Thailand vary widely because protocols vary widely.⁸⁹
• Treatment availability does not automatically mean Thai FDA registration.¹⁰
• More cells do not automatically mean better treatment.
• Diagnosis, product quality, physician expertise, manufacturing, and patient selection all matter.
  ‍

If there is one principle worth remembering, it is this: Do not compare “stem cell clinics.” Compare actual medical proposals.

‍

🌿 The Right Question Is Not Simply “Do Stem Cells Work for Knee Pain?”

The evidence around stem cell therapy for knee osteoarthritis sits between two extremes.

It is not the guaranteed cartilage-regeneration story sometimes used in regenerative medicine marketing.

But the research also does not suggest there is nothing worth investigating.

Randomized studies increasingly point toward potential improvements in pain and function.²³

Researchers are also studying possible structural effects and trying to identify which patients, products, and protocols may work best.

What we do not yet have is one universally accepted cell type, dose, protocol, or reliable method for rebuilding normal cartilage in advanced osteoarthritis.

For someone considering treatment in Thailand, the most important question is therefore not:

“Does this clinic offer stem cells?”

It is:

“Does this specific treatment, from this specific medical team, make biological and clinical sense for my knee?”

‍

Considering knee stem cell therapy in Thailand?

If you are comparing clinics, cell products, or treatment proposals, it can be difficult to know which details actually matter and which are simply part of the sales pitch.

STEMCIERGE helps international patients understand treatment options, compare proposals, and identify the questions worth asking before choosing a provider.

Get guidance on your case and understand your options before making a treatment decision.

‍

❓ Frequently Asked Questions

How much does stem cell therapy for knees cost in Thailand?

Stem cell therapy for knees in Thailand can start around ฿80,000 (or around $2,500 USD) for some publicly advertised single-knee procedures and rise into several hundred thousand baht for bilateral or larger regenerative medicine programs.⁸⁹

The total price depends on the cell product, dose, laboratory processing, physician fees, imaging, rehabilitation, follow-up, and other treatments included.
‍

Does stem cell therapy work for knee osteoarthritis?

Stem cell therapy may reduce pain and improve function in some people with knee osteoarthritis.

A 2025 Cochrane review found modest improvements compared with placebo, but rated the evidence as low certainty because the treatments, doses, and study designs varied substantially.²
‍

Can stem cells rebuild cartilage in the knee?

Some MSC studies have reported favorable cartilage-related MRI changes, but researchers have not consistently demonstrated regeneration of normal, durable articular cartilage.³⁴

Pain relief or improved mobility should therefore not automatically be described as cartilage regrowth.
‍

What is the best stage of osteoarthritis for stem cell therapy?

Some recent research suggests earlier-stage knee osteoarthritis may provide a more favorable setting for certain cell-based treatments than advanced KL grade IV disease.⁴

However, individual suitability depends on imaging, joint mechanics, symptoms, previous treatments, and treatment goals.
‍

Do stem cells work for bone-on-bone knee arthritis?

Stem cell therapy may still influence symptoms in some people with advanced osteoarthritis, but evidence is generally less convincing as structural damage becomes more severe.⁴

Stem cell injections should not be assumed to reverse major joint-space collapse, malalignment, or advanced mechanical degeneration.
‍

Which type of stem cell is best for knee osteoarthritis?

Researchers have not established one universally superior stem cell source for knee osteoarthritis.

Clinical studies have investigated adipose-derived MSCs, bone-marrow-derived MSCs, umbilical-cord-derived MSCs, and other cell-containing products using different doses and protocols.²³⁴
‍

Are umbilical-cord stem cells better for knee arthritis?

There is not enough high-quality evidence to conclude that umbilical-cord MSCs are universally better than other cell sources for knee osteoarthritis.

The exact product, dose, manufacturing process, clinical evidence, and patient population are more informative than tissue source alone.
‍

How long do knee stem cell injections last?

There is no reliable universal duration for the effects of knee stem cell therapy.

Different trials use different products and protocols, and patients respond differently. Many studies follow patients for approximately 6–24 months, while longer-term evidence remains limited.³
‍

Is knee stem cell therapy approved in Thailand?

Thailand has regulatory pathways covering advanced therapy medicinal products, including cell therapies.¹⁰

However, a stem cell treatment being available in Thailand does not automatically mean the exact product is Thai FDA registered. Patients should ask which regulatory or clinical-use pathway applies to the treatment being proposed.
‍

Is PRP or stem cell therapy better for knee osteoarthritis?

Neither PRP nor stem cell therapy is universally better for every person with knee osteoarthritis.

PRP has evidence supporting symptom improvement in some patients, while stem-cell-based therapies show encouraging but more heterogeneous results.²³¹¹ The better option depends on OA severity, joint mechanics, previous treatments, goals, and the exact biological product being considered.

‍

🔖 Medical Disclaimer

The information in this article is provided for educational purposes only and should not be considered medical advice, diagnosis, or a recommendation for treatment.

Stem cell and regenerative medicine therapies may not be appropriate for every patient, and outcomes can vary based on the individual, condition severity, cell product, treatment protocol, and medical provider.

Always consult a qualified, licensed healthcare professional before making decisions about knee osteoarthritis treatment or traveling abroad for medical care. Treatment availability, evidence, pricing, and regulatory requirements may change over time.

STEMCIERGE does not guarantee treatment outcomes, and inclusion of a therapy, clinic, study, or provider in this article should not be interpreted as a medical endorsement.

‍

📚 References

¹ World Health Organization. Osteoarthritis. WHO Fact Sheet.

² Whittle SL, et al. Stem cell injections for osteoarthritis of the knee. Cochrane Database of Systematic Reviews. 2025;4:CD013342.

³ Exploring the effectiveness and safety of stem cell therapy for repair of cartilage defects: a meta-analysis of randomized controlled trials. Frontiers in Cell and Developmental Biology. 2026.

⁴ Batista JD, et al. Intra-articular adipose-derived cell therapies for knee osteoarthritis: a systematic review of randomized controlled trials. Frontiers in Medicine. 2026.

⁵ American Academy of Orthopaedic Surgeons. Use of Stem Cells in Orthopaedics. OrthoInfo.

⁶ Tangkanjanavelukul P, et al. Cartilage Regeneration Potential in Early Osteoarthritis of the Knee: ADSC Therapy Versus Hyaluronic Acid. International Journal of Molecular Sciences. 2025;26(17):8476.

⁷ Yin F, et al. Contextual effects of mesenchymal stem cell injections for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine. 2025.

⁸ EDNA Wellness. Stem Cell Treatment for Knee Osteoarthritis in Bangkok. 2026. Commercial source used only for publicly advertised pricing examples.

⁹ Bookimed. Stem Cell Therapy for Knees Clinics in Thailand. Commercial marketplace source used for additional public pricing context.

¹⁰ Thai Food and Drug Administration. Road to ATMPs: Thai FDA Affirms Thailand Will Not Be Left Behind. 2026.

¹¹ American Academy of Orthopaedic Surgeons. Management of Osteoarthritis of the Knee (Non-Arthroplasty). Clinical Practice Guideline.